CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Italian Melanoma Intergroup (IMI)

doi:10.1016/j.ejca.2018.04.005

CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Italian Melanoma Intergroup (IMI)

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	59-61
Number of pages	3
Journal	European Journal of Cancer
Volume	97
DOIs	https://doi.org/10.1016/j.ejca.2018.04.005
Publication status	Published - Jul 1 2018

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.ejca.2018.04.005

Cite this

Italian Melanoma Intergroup (IMI) (2018). CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab. European Journal of Cancer, 97, 59-61. https://doi.org/10.1016/j.ejca.2018.04.005

@article{3ca3b525ebde4abdaee48451044e23cd,

title = "CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab",

author = "{Italian Melanoma Intergroup (IMI)} and Paola Queirolo and Beatrice Dozin and Anna Morabito and Barbara Banelli and Roberta Carosio and Vincenzo Fontana and Ferrucci, {Pier Francesco} and Chiara Martinoli and Emilia Cocorocchio and Ascierto, {Paolo A.} and Gabriele Madonna and Ester Simeone and {De Galitiis}, Federica and {Antonini Cappellini}, {Gian Carlo} and Paolo Marchetti and Michele Guida and Stefania Tommasi and Laura Ghilardi and Barbara Merelli and Paolo Fava and Simona Osella-Abate and Massimo Guidoboni and Massimo Romani and Diego Ferone and Francesco Spagnolo and Pistillo, {Maria Pia}",

year = "2018",

month = jul,

day = "1",

doi = "10.1016/j.ejca.2018.04.005",

language = "English",

volume = "97",

pages = "59--61",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

AU - Italian Melanoma Intergroup (IMI)

AU - Queirolo, Paola

AU - Dozin, Beatrice

AU - Morabito, Anna

AU - Banelli, Barbara

AU - Carosio, Roberta

AU - Fontana, Vincenzo

AU - Ferrucci, Pier Francesco

AU - Martinoli, Chiara

AU - Cocorocchio, Emilia

AU - Ascierto, Paolo A.

AU - Madonna, Gabriele

AU - Simeone, Ester

AU - De Galitiis, Federica

AU - Antonini Cappellini, Gian Carlo

AU - Marchetti, Paolo

AU - Guida, Michele

AU - Tommasi, Stefania

AU - Ghilardi, Laura

AU - Merelli, Barbara

AU - Fava, Paolo

AU - Osella-Abate, Simona

AU - Guidoboni, Massimo

AU - Romani, Massimo

AU - Ferone, Diego

AU - Spagnolo, Francesco

AU - Pistillo, Maria Pia

PY - 2018/7/1

Y1 - 2018/7/1

UR - http://www.scopus.com/inward/record.url?scp=85047747670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047747670&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2018.04.005

DO - 10.1016/j.ejca.2018.04.005

M3 - Letter

AN - SCOPUS:85047747670

VL - 97

SP - 59

EP - 61

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -